
Investors 1
Date | Name | Website |
- | TRITON FUN... | tritonfund... |
Mentions in press and media 1
Date | Title | Description |
26.01.2025 | Corstasis Therapeutics Inc. Announces FDA Acceptance of New Drug Application for Bumetanide Nasal Spray | PDUFA Target Action Date Set for September 14, 2025 HENDERSON, Nev.–(BUSINESS WIRE)–January 27, 2025– Corstasis Therapeutics Inc. (www.corstasis.com), a clinical-stage MedTech pharmaceutical company developing innovative, practical therapie... |